Anupam Rama Recent News
JPMorgan Believes Its Positive Long-Term Thesis On Alexion Remains Intact
4 Reasons JPMorgan Just Downgraded Merrimack Pharmaceuticals
Ignyta Gets A Bullish Initiation From JPMorgan
JPMorgan Upgrades Agios Pharma To Overweight Despite Last Week's 25% Decline
Rigel Pharma Gets Bulls From JPMorgan Before New Phase 3 Data: What To Know
JP Morgan Upgrades Alnylam Pharma To Overweight
UPDATE: J.P. Morgan Downgrades Amicus Therapeutics On Cautious View of Migalastat Monotherapy
Oppenheimer Rates Genzyme (GENZ) Perform